Related Experiment Video
Updated: Jun 2, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
Parathyroid hormone levels in long-term renal transplant children and adolescents
Isabella Guzzo1, Giacomo Di Zazzo, Chiara Laurenzi
1Nephrology and Urology Department, Bambino Gesù Children's Hospital and Research Institute (IRCCS), Piazza S. Onofrio 4, 00165 Rome, Italy. isabella.guzzo@opbg.net
Insights
Persistent hyperparathyroidism after kidney transplant is common in children but often resolves over time. Pre-transplant factors and dialysis duration predict its persistence, suggesting surgery is rarely needed.
Area of Science:
- Nephrology
- Endocrinology
- Pediatric Surgery
Background:
- Secondary hyperparathyroidism frequently complicates chronic renal failure.
- Kidney transplantation improves renal function but hyperparathyroidism persists in 50% of pediatric recipients.
- Understanding the long-term course and risk factors is crucial for managing persistent hyperparathyroidism post-transplant.
Purpose of the Study:
- To investigate the course of parathyroid hormone (PTH) levels in children after kidney transplantation.
- To identify potential risk factors associated with persistent hyperparathyroidism in this population.
Main Methods:
- A cohort of 145 pediatric kidney transplant recipients was studied with a mean follow-up of 4.7 years.
- Intact PTH (iPTH), calcium, and phosphorus levels were monitored pre- and post-transplant.
- Multivariate analysis was used to identify predictors of persistent hyperparathyroidism.
Main Results:
- Serum iPTH levels decreased significantly in the first 6 months and continued to decline long-term.
- Prevalence of hyperparathyroidism decreased from 69.1% at transplant to 47% at 1 year post-transplant.
- Pre-transplant hyperparathyroidism, longer dialysis duration, creatinine clearance, and hypophosphatemia predicted persistent disease.
Conclusions:
- Serum iPTH levels tend to normalize in the majority of children long after kidney transplantation.
- Parathyroidectomy should be reserved for a select group of pediatric kidney transplant recipients with persistent hyperparathyroidism.
Abstract:
Secondary hyperparathyroidism is a common complication of chronic renal failure. Kidney transplantation corrects renal insufficiency and most metabolic abnormalities but hyperparathyroidism persists in 50% of children after transplantation. The aim of this study was to investigate parathyroid hormone (PTH) course and potential risk factors for hyperparathyroidism in children after renal transplant. We collected data from 145 transplanted children (mean follow-up 4.7 years). Intact PTH level (iPTH) rapidly decreased in the first 6 months post-transplant and continued to decline in the following years. iPTH was above the normal range in 69.1% of the patients at the time of transplant and in 47% 1 year later, this improvement continuing thereafter. Hypercalcemia was present in 20.3% of the patients before transplant and in 6.3 and 4.1% of patients 6 months and 1 year after transplant, respectively. Hypophosphatemia was present in 5.5% of the patients at 6 months, and 45.5% of the patients needed phosphorus supplements during the first 6 months after transplant. Multivariate analysis indicated pre-transplant hyperparathyroidism, dialysis duration, creatinine clearance and hypophosphatemia as predictors of persistent hyperparathyroidism. In kidney transplanted children, serum iPTH normalized in the long term in the majority of cases. Thus, parathyroidectomy should be reserved for selected patients.
Related Concept Videos
Kidney Transplant III: Nursing Management
Kidney Transplant II: Surgical Procedure
Kidney Transplant I: Introduction
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Chronic Kidney Disease III: Interprofessional Care
